{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T20:20:06Z","timestamp":1774470006359,"version":"3.50.1"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0233703","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T17:41:29Z","timestamp":1590774089000},"page":"e0233703","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["\"I\u2019m going to stay young\":\u00a0 Belief in anti-aging efficacy of menopausal hormone therapy drives prolonged use despite medical risks"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2445-2648","authenticated-orcid":true,"given":"Mary M.","family":"Hunter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison J.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret I.","family":"Wallhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,5,29]]},"reference":[{"key":"pone.0233703.ref001","unstructured":"Martin, K and Barbieri, R. Treatment of menopausal symptoms with hormone therapy. https:\/\/www-uptodate-com.ucsf.idm.oclc.org\/contents\/treatment-of-menopausal-symptoms-with-hormone-therapy"},{"issue":"13","key":"pone.0233703.ref002","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials","volume":"310","author":"JE Manson","year":"2013","journal-title":"JAMA"},{"issue":"9084","key":"pone.0233703.ref003","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","article-title":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer","volume":"350","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1997","journal-title":"Lancet"},{"key":"pone.0233703.ref004","doi-asserted-by":"crossref","first-page":"l665","DOI":"10.1136\/bmj.l665","article-title":"Use of postmenopausal hormone therapy and risk of Alzheimer's disease in Finland: nationwide case-control study","volume":"364","author":"H Savolainen-Peltonen","year":"2019","journal-title":"BMJ"},{"issue":"6","key":"pone.0233703.ref005","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/GME.0000000000001054","article-title":"Trends in oral and vaginally administered estrogen use among US women 50 years of age or older with commercial health insurance","volume":"25","author":"JL Weissfeld","year":"2018","journal-title":"Menopause"},{"issue":"4","key":"pone.0233703.ref006","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.maturitas.2014.05.006","article-title":"From systemic hormone therapy to vaginal estrogen\u2014a nationwide register study in Finland, 2003\u20132012","volume":"78","author":"E Holm","year":"2014","journal-title":"Maturitas"},{"key":"pone.0233703.ref007","unstructured":"Hunter M. Hormone Therapy Decision Making in Older Women. https:\/\/escholarship.org\/uc\/item\/70v4k4b2"},{"issue":"10","key":"pone.0233703.ref008","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0277-9536(97)00091-9","article-title":"Decision-making and hormone replacement therapy: a qualitative analysis","volume":"45","author":"MS Hunter","year":"1997","journal-title":"Soc Sci Med"},{"key":"pone.0233703.ref009","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0531-5131(01)00490-3","article-title":"Attitudes towards menopause and hormone replacement therapy in different cultures","volume":"1229","author":"S Krishna","year":"2002","journal-title":"Internation Congress Series"},{"issue":"4","key":"pone.0233703.ref010","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.GME.0000148644.55486.36","article-title":"Hormone use and patient concerns after the findings of the Women's Health Initiative","volume":"12","author":"SJ Rolnick","year":"2005","journal-title":"Menopause"},{"key":"pone.0233703.ref011","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2296-7-61","article-title":"Hormone therapy after the Women's Health Initiative: a qualitative study","volume":"7","author":"LM French","year":"2006","journal-title":"BMC Fam Pract"},{"key":"pone.0233703.ref012","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1745-7599.2010.00553.x","article-title":"Women\u2019s decision making during the menopausal transition","volume":"22","author":"R Theroux","year":"2010","journal-title":"Journal of the American Academy of Nurse Practitioners"},{"key":"pone.0233703.ref013","unstructured":"Breastcancer.org. https:\/\/www.breastcancer.org\/symptoms\/understand_bc\/statistics"},{"issue":"4","key":"pone.0233703.ref014","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/jnci\/djq527","article-title":"Breast cancer risk in relation to the interval between menopause and starting hormone therapy","volume":"103","author":"V Beral","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"10204","key":"pone.0233703.ref015","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","article-title":"Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence","volume":"394","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2019","journal-title":"Lancet"},{"key":"pone.0233703.ref016","volume-title":"The menopause industry: How the medical establishment exploits women","author":"S Coney","year":"1994"},{"issue":"5","key":"pone.0233703.ref017","first-page":"489","article-title":"Compromising the medical literature: the hidden influence of industry-biased articles","volume":"84","author":"A Fugh-Berman","year":"2011","journal-title":"American Family Physician"},{"issue":"3","key":"pone.0233703.ref018","doi-asserted-by":"crossref","first-page":"e1000425","DOI":"10.1371\/journal.pmed.1000425","article-title":"Promotional tone in reviews of menopausal hormone therapy after the Women's Health Initiative: an analysis of published articles","volume":"8","author":"A Fugh-Berman","year":"2011","journal-title":"PLoS medicine"},{"issue":"9","key":"pone.0233703.ref019","doi-asserted-by":"crossref","first-page":"e1000335","DOI":"10.1371\/journal.pmed.1000335","article-title":"The haunting of medical journals: how ghostwriting sold \"HRT\"","volume":"7","author":"A Fugh-Berman","year":"2010","journal-title":"PLoS medicine"},{"issue":"1","key":"pone.0233703.ref020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1353\/pbm.2006.0006","article-title":"Gynecologists and estrogen: an affair of the heart","volume":"49","author":"A Fugh-Berman","year":"2006","journal-title":"Perspectives in biology and medicine"},{"key":"pone.0233703.ref021","unstructured":"Wilson D. Wyeth\u2019s Use of Medical Ghostwriters Questioned: New York Times; 2008. https:\/\/www.nytimes.com\/2008\/12\/13\/business\/13wyeth.html"},{"key":"pone.0233703.ref022","unstructured":"Wyeth and Ghostwriting. https:\/\/www.industrydocuments.ucsf.edu\/drug\/results\/#q=Wyeth%20and%20hormone%20therapy&h=%7B%22hideDuplicates%22%3Atrue%2C%22hideFolders%22%3Atrue%7D&subsite=drug&cache=true&count=238"},{"issue":"6","key":"pone.0233703.ref023","first-page":"1021","article-title":"A review of postmenopausal hormone therapy recommendations: potential for selection bias","volume":"82","author":"E Hemminki","year":"1993","journal-title":"Obstet Gynecol"},{"issue":"1","key":"pone.0233703.ref024","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.291.1.47","article-title":"National use of postmenopausal hormone therapy: annual trends and response to recent evidence","volume":"291","author":"AL Hersh","year":"2004","journal-title":"JAMA"},{"issue":"12","key":"pone.0233703.ref025","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/GME.0000000000000553","article-title":"Use of compounded hormone therapy in the United States: report of The North American Menopause Society Survey","volume":"22","author":"ML Gass","year":"2015","journal-title":"Menopause"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0233703","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T17:41:46Z","timestamp":1590774106000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0233703"}},"subtitle":[],"editor":[{"given":"Antonio Simone","family":"Lagan\u00e0","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0233703","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,29]]}}}